https://www.selleckchem.com/pr....oducts/nsc-663284.ht
ram, predicting the risk of recurrence and stratifying HCC patient management will yield the greatest survival benefit for patients.Alternative splicing is deregulated in cancer and alternatively spliced products can be linked to cancer hallmarks. Targeting alternative splicing could offer novel effective cancer treatments. We investigated the effects of the crude extract of a South African medicinal plant, Cotyledon orbiculata, on cell survival of colon (HCT116) and esophageal (OE33 and KYSE7 cancer cell lines. Using RNASeq, we di
Мне нравится
Комментарий
Перепост
